Australia has recorded its first death from diphtheria in over 30 years, as the country grapples with its worst outbreak of the bacterial infection since the 1990s. Health authorities confirmed the fatality in a child from New South Wales, who had not been fully vaccinated. The case has reignited concerns about vaccine hesitancy and its deadly consequences, even in high-income nations.
Diphtheria, once a leading cause of child mortality, is now rare in countries with high vaccination coverage. However, pockets of low immunisation have allowed the highly contagious pathogen to resurface. The Australian outbreak, which began in late 2022 in the Northern Territory and Queensland, has now spread to New South Wales and Victoria. Over 30 cases have been reported in 2023 alone, a stark rise from the typical annual count of zero or one.
The bacterium *Corynebacterium diphtheriae* produces a toxin that can cause a thick grey coating in the throat, leading to severe breathing difficulties, heart failure, paralysis, and death. Fatality rates can reach up to 10% even with treatment; without it, they climb to 30-50%. The deceased child is believed to have contracted the infection from an unvaccinated household contact.
Dr Paul Kelly, Australia’s Chief Medical Officer, stated: “This is a tragic but preventable death. Diphtheria is a disease of the unvaccinated. Our priority is to boost immunisation rates in affected communities.” The outbreak has been concentrated among Indigenous communities and anti-vaccination groups, echoing a pattern seen in other vaccine-preventable disease resurgences.
For British travellers, the risk of infection is low but not negligible. The UK Health Security Agency has updated its travel advice, urging anyone heading to affected areas in Australia to ensure they have received a full course of the diphtheria vaccine, which is typically given as part of the childhood immunisation programme. Adults should also have received a booster within the last 10 years. The UK has not seen a diphtheria death since 1994, but unvaccinated individuals remain vulnerable globally.
The outbreak in Australia serves as a stark reminder that infectious diseases are just a plane ride away. As antiviral and antibiotic resistance rise, and immunisation rates waver, the global community faces a slow erosion of hard-won public health gains. The climate crisis may further destabilise these systems, as extreme weather events disrupt healthcare infrastructure and population movements.
While diphtheria is treatable with antitoxin and antibiotics, the effectiveness hinges on rapid diagnosis. Symptoms begin with a sore throat, fever, and swollen lymph nodes, but the hallmark membrane in the throat may take up to a week to develop. Travellers who experience these symptoms after returning from Australia should seek immediate medical attention.
Australia's health authorities are conducting contact tracing and offering prophylactic antibiotics to close contacts. They have also launched a targeted vaccination campaign in affected areas. However, entrenched anti-vaccination sentiments in some communities pose a significant challenge to containment.
The news of a diphtheria death in the 21st century should serve as a warning for the UK. With vaccine hesitancy on the rise post-COVID-19, and international travel resurgent, the possibility of reintroducing previously controlled diseases is very real. The public health system must remain vigilant, and individuals must take responsibility for their own immunisation status.
In an era of climate change, where ecological disruptions can amplify pathogen spread, the importance of maintaining robust vaccination coverage cannot be overstated. This is a public health imperative that transcends borders. The loss of a child to a vaccine-preventable disease is a tragedy that should never have happened. Her death should galvanise action, not just in Australia, but globally.
